» Articles » PMID: 38528009

A Systematic Review and Meta-analysis of Socio-cognitive Impairments in Multiple Sclerosis

Overview
Journal Sci Rep
Specialty Science
Date 2024 Mar 26
PMID 38528009
Authors
Affiliations
Soon will be listed here.
Abstract

Socio-cognitive impairment is frequent in multiple sclerosis (MS). However, little is known about the relationship between other potentially relevant clinical symptoms (i.e., cognition, depression, fatigue) and the degree of socio-cognitive impairment, and neural mechanisms underlying socio-cognitive deficits in MS. Therefore, we meta-analytically quantified socio-cognitive impairment in MS. A systematic literature search in MEDLINE Ovid, Web of Science Core Collection, CENTRAL, and PsycInfo was conducted until December 2022. Studies investigating affective or cognitive theory of mind (a/cToM), visual perspective taking (VPT) and social decision making (SDM) in MS patients relative to healthy controls were included. Risk-of-bias (RoB) was assessed using the CLARITY group "Tool for Assessing RoB in Cohort Studies". Mediation analysis investigated the contribution of clinical symptoms to socio-cognitive impairment. In total, n = 8534 studies were screened, 58 were included in the systematic review, 27 in the meta-analyses. Most studies were rated with a moderate RoB. Meta-analyses confirmed impairment of both aToM and cToM in MS patients, with larger effect sizes for aToM. Mediation analysis demonstrated that higher levels of fatigue selectively predicted the degree of cToM impairment. There was insufficient data available to quantify impairment in other socio-cognitive domains. Fourteen structural and functional imaging studies were identified and characterized by substantial heterogeneity. Summarized, this study confirmed substantial socio-cognitive impairment in MS and highlights the potential exacerbating role of comorbid clinical symptoms. We identify several evidence gaps that need to be addressed in future large-scale studies using comprehensive and coordinated assessments of socio-cognitive parameters, potential mediators, and neural correlates.Trial registration: The pre-registered review protocol can be assessed at www.crd.york.ac.uk/PROSPERO/ (ID: CRD42020206225).

Citing Articles

The 36-Item Yoni Task: Normative Data for the Clinical Assessment of Theory of Mind.

Isernia S, Rossetto F, Marchetti A, Baglio F J Clin Med. 2024; 13(21).

PMID: 39518473 PMC: 11546506. DOI: 10.3390/jcm13216334.

References
1.
Pfaff L, Gounot D, Chanson J, De Seze J, Blanc F . Emotional experience is increased and emotion recognition decreased in multiple sclerosis. Sci Rep. 2021; 11(1):21885. PMC: 8575874. DOI: 10.1038/s41598-021-01139-z. View

2.
Banati M, Sandor J, Mike A, Illes E, Bors L, Feldmann A . Social cognition and Theory of Mind in patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 2009; 17(3):426-33. DOI: 10.1111/j.1468-1331.2009.02836.x. View

3.
Batista S, dAlmeida O, Afonso A, Freitas S, Macario C, Sousa L . Impairment of social cognition in multiple sclerosis: Amygdala atrophy is the main predictor. Mult Scler. 2017; 23(10):1358-1366. DOI: 10.1177/1352458516680750. View

4.
Yokote H, Okano K, Toru S . Theory of mind and its neuroanatomical correlates in people with multiple sclerosis. Mult Scler Relat Disord. 2021; 55:103156. DOI: 10.1016/j.msard.2021.103156. View

5.
Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535. PMC: 2714657. DOI: 10.1136/bmj.b2535. View